Stocktoria

ABBOTT LABORATORIES ABT

NYSE · stock · Pharmaceutical Preparations · website · IPO 1937-03-01 · LEI

ABBOTT LABORATORIES statistics & valuation

Market cap$163.9B
P / E25.1×
P / S3.7×
P / B3.1×
P / FCF22.2×
Dividend yield2.51%
Net margin14.7%
Return on equity12.4%
FCF margin16.7%
Net debt$4.4B
Net debt / EBITDA0.5×
Enterprise value USD$168.3B
EV / EBITDA17.7×
Earnings yield EBIT/EV4.8%
Return on capital11.5%
Graham number -54.7%$50.27

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($50.27); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
6.70% 1.70% 7.70% 11.60% 13.00% 16.40% 15.90% 14.30% 31.90% 14.70% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
14.50% 5.70% 11.90% 14.20% 15.50% 19.60% 19.20% 16.20% 16.30% 18.20% 2016201720182019202020212022202320242025
Return on equity (%)
6.80% 1.50% 7.70% 11.80% 13.60% 19.60% 18.80% 14.70% 28.00% 12.40% 2016201720182019202020212022202320242025
Shares outstanding
1.48B 1.75B 1.77B 1.78B 1.79B 1.79B 1.76B 1.75B 1.75B 1.75B 2016201720182019202020212022202320242025
Net debt ($)
$2.06B $18.31B $15.52B $14.08B $11.70B $8.25B $6.89B $7.78B $6.51B $4.41B 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
2.70% 0.60% 3.50% 5.40% 6.20% 9.40% 9.30% 7.80% 16.50% 7.50% 2016201720182019202020212022202320242025
Free cash flow margin (%)
10.00% 16.20% 16.00% 14.10% 16.50% 20.10% 17.90% 12.60% 15.10% 16.70% 2016201720182019202020212022202320242025
Debt / equity (×)
1.00× 0.89× 0.63× 0.57× 0.56× 0.50× 0.45× 0.38× 0.29× 0.25× 2016201720182019202020212022202320242025
EPS ($)
$0.94 $0.27 $1.33 $2.06 $2.50 $3.94 $3.91 $3.26 $7.64 $3.72 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

ABBOTT LABORATORIES trades at about 29.8× earnings — below its 10-year norm (10-year range 16.7×–230.2×, median 42.3×).

16.7× 230.2×

Shaded band = 10-year range (16.7×–230.2×); dot = today's 29.8×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin18.2%16.3%16.2%19.2%19.6%15.5%14.2%11.9%5.7%14.5%
Net margin14.7%31.9%14.3%15.9%16.4%13.0%11.6%7.7%1.7%6.7%
FCF margin16.7%15.1%12.6%17.9%20.1%16.5%14.1%16.0%16.2%10.0%
Return on assets7.5%16.5%7.8%9.3%9.4%6.2%5.4%3.5%0.6%2.7%
Return on equity12.4%28.0%14.7%18.8%19.6%13.6%11.8%7.7%1.5%6.8%
Debt / equity0.25×0.29×0.38×0.45×0.50×0.56×0.57×0.63×0.89×1.00×
Current ratio1.581.671.641.631.851.721.441.622.264.02

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.